MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 26.02
+0.54 (2.12%)
Jan 12, 2026, 11:44 AM CET
MedinCell Market Cap
MedinCell has a market cap or net worth of €843.46 million as of January 12, 2026. Its market cap has increased by 73.63% in one year.
Market Cap
843.46M
Enterprise Value
863.55M
Revenue
32.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
€26.02
Market Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 843.46M, an increase of 477.29%. That is a compound annual growth rate of 27.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 843.46M | 1.11% |
| Dec 31, 2025 | 834.19M | 71.72% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 128.15B |
| Sanofi | 102.75B |
| Sartorius Stedim Biotech | 20.85B |
| bioMérieux | 13.33B |
| Eurofins Scientific SE | 12.24B |
| Ipsen | 10.46B |
| ABIVAX Société Anonyme | 7.71B |
| Virbac | 3.05B |